Trials / Sponsors / Hanscom, Thomas, M.D.
Hanscom, Thomas, M.D.
Individual · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Macular Edema | Phase 1 / Phase 2 | 2011-11-01 |